{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:26:02Z","timestamp":1789129562452,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018708","name":"Euratom Research and Training Programme","doi-asserted-by":"publisher","award":["755523"],"award-info":[{"award-number":["755523"]}],"id":[{"id":"10.13039\/100018708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ctro.2026.101251","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:40:58Z","timestamp":1786549258000},"page":"101251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of effective dose to the immune cells on survival in breast cancer patients"],"prefix":"10.1016","volume":"61","author":[{"given":"Stefanie A.","family":"de Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan S.","family":"Spoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Maduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter R.A.J.","family":"Deseyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina T.","family":"Muijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna M.","family":"Sijtsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne P.M.","family":"de Vette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne V.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewoud","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P.G.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9804","key":"10.1016\/j.ctro.2026.101251_bb0005","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"issue":"9935","key":"10.1016\/j.ctro.2026.101251_bb0010","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ctro.2026.101251_bb0015","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101251_bb0020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2026.101251_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116055","article-title":"Predicting acute coronary events after breast cancer radiotherapy: integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study","volume":"231","author":"Spoor","year":"2025","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2026.101251_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.radonc.2016.04.025","article-title":"Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation","volume":"119","author":"Tucker","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2017.09.004","article-title":"Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy","volume":"125","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101251_bb0040","first-page":"17","article-title":"Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy","volume":"17","author":"Xu","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101251_bb0045","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101251_bb0050","article-title":"Radiation induced lymphopenia is associated with the effective dose to the circulating immune cells in breast cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101251_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"issue":"11","key":"10.1016\/j.ctro.2026.101251_bb0060","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/1759-7714.13621","article-title":"Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer","volume":"11","author":"Matiello","year":"2020","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","article-title":"Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy","volume":"99","author":"Davuluri","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2019.11.398","article-title":"Systemic inflammation after radiation predicts locoregional recurrence, progression, and mortality in stage II-III triple-negative breast cancer","volume":"108","author":"Sherry","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2026.101251_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101251_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fonc.2020.00153","article-title":"Heart dosimetric parameters were associated with cardiac events and overall survival for patients with locally advanced esophageal cancer receiving definitive radiotherapy","volume":"10","author":"Cai","year":"2020","journal-title":"Front Oncol"},{"issue":"24","key":"10.1016\/j.ctro.2026.101251_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246193","article-title":"Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: a secondary analysis of RTOG0617","volume":"13","author":"Jin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2020.02.633","article-title":"Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy","volume":"108","author":"Sun","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1748-717X-3-6","article-title":"Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy","volume":"3","author":"van der Laan","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101251_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.radonc.2021.07.025","article-title":"Validation of separate multi-atlases for auto segmentation of cardiac substructures in CT-scans acquired in deep inspiration breath hold and free breathing","volume":"163","author":"Spoor","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101251_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2019.11.014","article-title":"A framework for modeling radiation induced lymphopenia in radiotherapy","volume":"144","author":"Jin","year":"2020","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101251_bb0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Investig"},{"key":"10.1016\/j.ctro.2026.101251_bb0120","series-title":"Multiple imputation for nonresponse in surveys","volume":"vol. 81","author":"Rubin","year":"2004"},{"key":"10.1016\/j.ctro.2026.101251_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.09.008","article-title":"Reverse cardio-oncology: exploring the effects of cardiovascular disease on cancer pathogenesis","volume":"163","author":"Koelwyn","year":"2022","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0130","first-page":"24","article-title":"A new classification of cardio-oncology syndromes","volume":"7","author":"de Boer","year":"2021","journal-title":"Cardiooncology"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0135","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1038\/s41598-019-45014-4","article-title":"Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies","volume":"9","author":"Seretis","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ctro.2026.101251_bb0140","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.clon.2023.04.003","article-title":"Prediction of radiation-induced lymphopenia following exposure of the thoracic region and associated risk of infections and mortality","volume":"35","author":"Terrones-Campos","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2017.11.022","article-title":"Exposure of the lungs in breast cancer radiotherapy: a systematic review of lung doses published 2010\u20132015","volume":"126","author":"Aznar","year":"2018","journal-title":"Radiother Oncol"},{"issue":"15","key":"10.1016\/j.ctro.2026.101251_bb0150","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101251_bb0155","article-title":"Potential determinants for radiation-induced lymphopenia in patients with breast cancer using interpretable machine learning approach","volume":"13","author":"Yu","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101251_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10585-017-9867-5","article-title":"Radiation therapy-induced metastasis: radiobiology and clinical implications","volume":"35","author":"Blyth","year":"2018","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"10.1016\/j.ctro.2026.101251_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011222","article-title":"Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis","volume":"5","author":"Sofia Vala","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ctro.2026.101251_bb0170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101251_bb0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2020.02.015","article-title":"The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy","volume":"146","author":"Xu","year":"2020","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101251_bb0180","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.adro.2020.03.021","article-title":"Lymphopenia and radiation dose to circulating lymphocytes with neoadjuvant chemoradiation in esophageal squamous cell carcinoma","volume":"5","author":"So","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101251_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","article-title":"The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy","volume":"133","author":"Deng","year":"2019","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101251_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Investig"},{"issue":"10","key":"10.1016\/j.ctro.2026.101251_bb0195","article-title":"Radiation-induced lymphopenia is a causal mediator of survival after chemoradiation therapy for esophagus cancer","volume":"9","author":"Chen","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2014.04.009","article-title":"Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy","volume":"112","author":"Shah","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jmrs.96","article-title":"Review of deep inspiration breath-hold techniques for the treatment of breast cancer","volume":"62","author":"Latty","year":"2015","journal-title":"J Med Radiat Sci"},{"issue":"1","key":"10.1016\/j.ctro.2026.101251_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-8-71","article-title":"Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery","volume":"8","author":"MacDonald","year":"2013","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101251_bb0215","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2009.02.062","article-title":"Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?","volume":"76","author":"Ares","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101251_bb0220","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0360-3016(02)04210-4","article-title":"Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes","volume":"55","author":"Lomax","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ctro.2026.101251_bb0225","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00066-024-02263-1","article-title":"Proton therapy reduces the effective dose to immune cells in breast cancer patients","volume":"200","author":"Loap","year":"2024","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101251_bb0230","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ctro.2026.101251_bb0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00066-024-02240-8","article-title":"Determinants of radiation dose to immune cells during breast radiotherapy","volume":"201","author":"Loap","year":"2025","journal-title":"Strahlenther Onkol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:22:12Z","timestamp":1789125732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"alternative-id":["S2405630826001461"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101251","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of effective dose to the immune cells on survival in breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101251"}}